Namur (Belgium), 13 January 2023
Vésale Bioscience is developing innovative precision phage therapy solutions to treat bacterial infections resistant to antibiotics, and today announces that it has received a €1.8 million grant from the European Innovation Council to accelerate the development of its diagnostic tool enabling personalized phage therapies.
More info via eric.poskin@phage.health, Spokesman – Corporate & Strategy Communication Director.